We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Aushon Launches New SignaturePLUS™ System for Multiplex Protein Biomarker Analysis

Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Aushon Launches New SignaturePLUS™ System for Multiplex Protein Biomarker Analysis"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Aushon has announced the global launch of its next generation SignaturePLUS™ Imaging and Analysis System. The SignaturePLUS system is designed to meet the cost and performance needs of researchers for accurate, reproducible, and reliable multiplex protein biomarker analysis across pre-clinical, clinical and diagnostics applications in all therapeutic areas.

The SignaturePLUS™system incorporates an advanced CCD imager with custom optics designed specifically for quantitative chemiluminescent protein arrays. Its sleek, compact design uses less than 2 feet of bench space and includes an integrated iPad® user interface with an embedded Mac mini® computer that eliminates the need for separate, bulky system components. The SignaturePLUS system also includes the enhanced PROarray® Analyst software for fast, accurate, reproducible analysis.

Engineered for simple, out-of-the-box setup, the SignaturePLUS system is extremely easy to use and features typical imaging times of less than 2 minutes per plate.

Aushon’s multiplex platform was recently validated in multiple late stage clinical trials and showed excellent correlation with the traditional single-plex ELISA, yet demonstrated all the advantages associated with multiplexing including significantly reduced sample consumption, lower cost per data point, and a substantial increase in overall lab productivity.

Researchers can choose from Aushon’s growing menu of more than 300 validated protein biomarkers for analysis using the new SignaturePLUS system.